Probiotics show promise in stopping autoimmune diseases before they start
NCT ID NCT04014660
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving a daily mix of two types of friendly bacteria (Lactobacilli) to children at genetic risk could prevent or slow down autoimmune diseases like celiac disease, type 1 diabetes, and thyroid problems. The researchers enrolled 202 children who already had early signs of autoimmunity (specific antibodies in their blood). The goal was to see if these probiotics could calm the immune system and protect the gut, potentially stopping the disease from developing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELIAC DISEASE IN CHILDREN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Research Center (CRC), Bldng 60:11
Malmö, 20502, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an app and cash rewards tame type 1 diabetes in young adults?
- Smart insulin pump aims to end dangerous nighttime blood sugar swings
- Could diabetes be silently damaging your hearing?
- Could a lesson in Gluten-Free eating boost Kids' health?
- Hidden liver risk in type 1 diabetes: a new study investigates
- Can a wearable sensor outsmart diabetic ketoacidosis?